Multiple signaling pathways and proteins

The term 'Multiple signaling pathways and proteins' is a broad, non-specific designation rather than a single, discrete molecular target such as a receptor or enzyme. It encompasses various intracellular cascades, such as the PI3K/Akt, MAPK/ERK, and JAK/STAT pathways, which are essential for regulating cell growth, survival, and metabolism (Source: NIH). Because it refers to a collection of diverse proteins—including receptors, enzymes, and transcription factors—it lacks a unique identifier in databases like UniProt or ChEMBL. In drug discovery, this phrase often describes the activity of multi-target inhibitors or therapies that address the complexity of diseases like cancer and systemic inflammation (Source: Nature Reviews Drug Discovery). However, the lack of specificity makes it an 'incorrect' entry for structured target annotation, as it does not define a discrete site of drug action. Targeting multiple pathways simultaneously can overcome drug resistance but often presents significant challenges regarding off-target toxicity and safety (Source: PubMed). Analysts should treat this term as a functional category or a description of polypharmacology rather than a specific protein or receptor.

Other names

Multi-targetSignaling networksPleiotropic targets

Not applicable as this is a generic category rather than a specific molecular target.